WordNet

small room in which a monk or nun lives (同)cubicle
a device that delivers an electric current as the result of a chemical reaction (同)electric cell
a room where a prisoner is kept (同)jail cell, prison cell
(biology) the basic structural and functional unit of all organisms; they may exist as independent units of life (as in monads) or may form colonies or tissues as in higher plants and animals
any small compartment; "the cells of a honeycomb"
a small unit serving as part of or as the nucleus of a larger political movement (同)cadre
pertaining to the formation of blood or blood cells; "hemopoietic stem cells in bone marrow" (同)haematopoietic, hemopoietic, haemopoietic, hematogenic, haematogenic

PrepTutorEJDIC

(刑務所の)『独房』;(修道院の)小さい独居室 / (ミツバチの)みつ房,巣穴 / 小さい部屋 / 『細胞』 / 電池 / 花粉室 / (共産党などの)細胞

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2016/06/03 03:03:08」(JST)

wiki en

Diagram showing the development of different blood cells from haematopoietic stem cells to mature cells.

A blood cell, also called a haematopoietic cell, hemocyte, or hematocyte, is a cell produced through hematopoiesis and found mainly in the blood. In mammals, these fall into three general categories:

Red blood cells – Erythrocytes
White blood cells – Leukocytes
Platelets – Thrombocytes.

Together, these three kinds of blood cells add up to a total 45% of the blood tissue by volume, with the remaining 55% of the volume composed of plasma, the liquid component of blood.^[1] The volume percentage of red blood cells in the blood (hematocrit) is measured by centrifuge or flow cytometry and is 45% of cells to total volume in males and 40% in females.^[2]

Haemoglobin (the main component of red blood cells) is an iron-containing protein that facilitates transportation of oxygen from the lungs to tissues and carbon dioxide from tissues to the lungs.

Red blood cells

Red and white human blood cells as seen under a microscope using a blue slide stain

Scanning electron microscope image of circulating human blood, showing red and white blood cells (a few lymphocytes, monocytes, neutrophils), and disc-shaped platelets

Red blood cells or erythrocytes, primarily carry oxygen and collect carbon dioxide through the use of haemoglobin, and have a lifetime of about 120 days. In the process of being formed they go through a unipotent stem cell stage. They have the job alongside the white blood cells of protecting the healthy cells.

RBcs are formed in the red bone marrow in the adults.After the completion of their lifespan,they are destroyed in the spleen.

White blood cells

White blood cells or leukocytes, are cells of the immune system involved in defending the body against both infectious disease and foreign materials. Five diverse types of leukocytes exist, and are all produced and derived from multipotent cells in the bone marrow known as a hematopoietic stem cells. They live for about 3 to 4 days in the average human body. Leukocytes are found throughout the body, including the blood and lymphatic system.

The two main categories of white blood cells are granulocytes and agranulocytes.

Neutrophils (a type of granulocyte) are the most abundant of all the WBCs.

Platelets

Platelets, or thrombocytes or yellow blood cells, are very small, irregularly shaped clear cell fragments (i.e. cells that do not have a nucleus containing DNA), 2–3 µm in diameter, which derive from fragmentation of precursor megakaryocytes. The average lifespan of a platelet is normally just 5 to 9 days. Platelets are a natural source of growth factors. They circulate in the blood of mammals and are involved in hemostasis, leading to the formation of blood clots. Platelets release thread-like fibers to form these clots.

If the number of platelets is too low, excessive bleeding can occur. However, if the number of platelets is too high, blood clots can form thrombosis, which may obstruct blood vessels and result in such events as a stroke, myocardial infarction, pulmonary embolism—or blockage of blood vessels to other parts of the body, such as the extremities of the arms or legs. An abnormality or disease of the platelets is called a thrombocytopathy, which can be either a low number of platelets (thrombocytopenia), a decrease in function of platelets (thrombasthenia), or an increase in the number of platelets (thrombocytosis). There are disorders that reduce the number of platelets, such as heparin-induced thrombocytopenia (HIT) or thrombotic thrombocytopenic purpura (TTP), that typically cause thromboses, or clots, instead of bleeding.

Platelets release a multitude of growth factors including Platelet-derived growth factor (PDGF), a potent chemotactic agent, and TGF beta, which stimulates the deposition of extracellular matrix. Both of these growth factors have been shown to play a significant role in the repair and regeneration of connective tissues. Other healing-associated growth factors produced by platelets include basic fibroblast growth factor, insulin-like growth factor 1, platelet-derived epidermal growth factor, and vascular endothelial growth factor. Local application of these factors in increased concentrations through Platelet-rich plasma (PRP) has been used as an adjunct to wound healing for several decades.

Complete blood count

Blood components

A complete blood count (CBC) is a test panel requested by a doctor or other medical professional that gives information about the cells in a patient's blood. A scientist or lab technician performs the requested testing and provides the requesting medical professional with the results of the CBC. In the past, counting the cells in a patient's blood was performed manually, by viewing a slide prepared with a sample of the patient's blood under a microscope. Today, this process is generally automated by use of an automated analyzer, with only approximately 10-20% of samples now being examined manually. Abnormally high or low counts may indicate the presence of many forms of disease, and hence blood counts are amongst the most commonly performed blood tests in medicine, as they can provide an overview of a patient's general health status.

Discovery

In 1658 Dutch naturalist Jan Swammerdam was the first person to observe red blood cells under a microscope, and in 1695, microscopist Antoni van Leeuwenhoek, also Dutch, was the first to draw an illustration of "red corpuscles", as they were called. No further blood cells were discovered until 1842 when French physician Alfred Donné discovered platelets. The following year leukocytes were first observed by Gabriel Andral, a French professor of medicine, and William Addison, a British physician, simultaneously. Both men believed that both red and white cells were altered in disease. With these discoveries, hematology, a new field of medicine, was established. Even though agents for staining tissues and cells were available, almost no advances were made in knowledge about the morphology of blood cells until 1879, when Paul Ehrlich published his technique for staining blood films and his method for differential blood cell counting ^[3]

References

^ Maton, Anthea; Jean Hopkins; Charles William McLaughlin; Susan Johnson; Maryanna Quon Warner; David LaHart; Jill D. Wright (1993). Human Biology and Health. Englewood Cliffs, New Jersey, USA: Prentice Hall. ISBN 0-13-981176-1.
^ Purves, William K.; Sadava, David; Orians, Gordon H.; Heller, H. Craig (2004). Life: The Science of Biology (7th ed.). Sunderland, Mass: Sinauer Associates. p. 954. ISBN 0-7167-9856-5.
^ http://www.annclinlabsci.org/content/33/2/237.full.pdf

External links

Biology portal

Find more about Blood cell at Wikipedia's sister projects
	Definitions from Wiktionary
	Media from Commons
	News stories from Wikinews
	Quotations from Wikiquote
	Source texts from Wikisource
	Textbooks from Wikibooks
	Learning resources from Wikiversity

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 造血細胞移植後の感染症の概要 overview of infections following hematopoietic cell transplantation
2. 造血細胞移植後生存者へのアプローチ the approach to hematopoietic cell transplantation survivorship
3. 造血細胞移植のためのドナー選定 donor selection for hematopoietic cell transplantation
4. 同種造血細胞移植の適応判定 determining eligibility for allogeneic hematopoietic cell transplantation
5. HLAハプロタイプ適合造血細胞移植 hla haploidentical hematopoietic cell transplantation

English Journal

Hepatic differentiation from human mesenchymal stem cells on a novel nanofiber scaffold.

Ghaedi M, Soleimani M, Shabani I, Duan Y, Lotfi AS.SourceDepartment of Clinical Biochemistry, Faculty of Medical Science, Tarbiat Modares University, Tehran, I.R. Iran.
Cellular & molecular biology letters.Cell Mol Biol Lett.2012 Mar;17(1):89-106. Epub 2011 Dec 28.
The emerging fields of tissue engineering and biomaterials have begun to provide potential treatment options for liver failure. The goal of the present study is to investigate the ability of a poly L-lactic acid (PLLA) nanofiber scaffold to support and enhance hepatic differentiation of human bone m
PMID 22207333

Down-regulation of Thanatos-associated protein 11 by BCR-ABL promotes CML cell proliferation through c-Myc expression.

Nakamura S, Yokota D, Tan L, Nagata Y, Takemura T, Hirano I, Shigeno K, Shibata K, Fujisawa S, Ohnishi K.SourceDepartment of Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan. satonaka@hama-med.ac.jp.
International journal of cancer. Journal international du cancer.Int J Cancer.2012 Mar 1;130(5):1046-59. doi: 10.1002/ijc.26065. Epub 2011 May 9.
Bcr-Abl activates various signaling pathways in chronic myelogenous leukemia (CML) cells. The proliferation of Bcr-Abl transformed cells is promoted by c-Myc through the activation of Akt, JAK2 and NF-κB. However, the mechanism by which c-Myc regulates CML cell proliferation is unclear. In our stud
PMID 21400515